Nestle NESN-1.51%decrease ... on Tuesday tempered its profitability expectations for next year as it steps up spending to boost its top line and win market share in a tough consumer environment.

Nestlé’s efforts to attract users of GLP-1 drugs in the US now include the launch of a range of protein shots.